Literature DB >> 35292750

Nivolumab plus chemotherapy or ipilimumab for advanced oesophageal squamous cell carcinoma.

Jordan Hindson1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35292750     DOI： 10.1038/s41575-022-00601-1

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  1 in total

Review 1.  Immunotherapy for the Treatment of Squamous Cell Carcinoma: Potential Benefits and Challenges.

Authors:  Tuba M Ansary; M D Razib Hossain; Mayumi Komine; Mamitaro Ohtsuki
Journal:  Int J Mol Sci       Date:  2022-08-01       Impact factor: 6.208
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.